The prevalence of Diabetes in older population rises with advancing age. Numerous recent studies run to prove that the effectiveness of laparoscopic sleeve gastrectomy (LSG) in type 2 diabetes treatment and to discover the mechanisms of diabetes remission and improvement in glucose homeostasis after LSG, yet its results are still unclear. The aim of study is the assessment of the effectiveness of LSG in glycemic control of type 2 DM.
Methods: Observational study including prospective and retrospective data analysis of glycemic control post LSG surgery for 60 elder Patient ≥ 60 year, with obesity ≥ 35 kg/m2 who suffer from T2DM and follow up in Helwan University surgery clinic from February 2022 to July 2023.
Results: 60 obese patients with mean age of 64.8 years, males and females. Mean BMI was 42.6 kg/m2. Significant Reduction in mean HbA1c, from 9.2±1.4 pre to 6±0.9 at 12m postoperative. Insulin therapy reduced from 63% (38 patients) to 23.3% (14 patients). 35 patient (58.3%) have complete remission from T2DM. Significant reduction in mean TC 252.8 ±27 to 185.8 ±30 and mean TG 156.4 ±15 to 136.8 ±34 and mean LDL 180 ±21 to 130 ±40 mg/dl.
Conclusion: the significant association between LSG and postoperative improvement or resolution of T2DM and dyslipidemia ≥ 60 years, makes no doubt that the indication for LSG as a metabolic surgery is fully present even at an advanced age.